![Carole Faig](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Carole Faig
Direktor/Vorstandsmitglied bei HENRY SCHEIN, INC.
Vermögen: 184 678 $ am 31.05.2024
Profil
Carole T.
Faig is an Independent Director at Henry Schein, Inc., QuVa Pharma, Inc., and Affinia Therapeutics, Inc. She previously served as an Independent Director at Cue Health, Inc. and as a Partner at Ernst & Young LLP.
Ms. Faig obtained her undergraduate degree from Sam Houston State University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
HENRY SCHEIN, INC.
0,00% | 04.03.2024 | 2 604 ( 0,00% ) | 180 561 $ | 31.05.2024 |
CUE HEALTH INC.
0,04% | 31.03.2024 | 60 543 ( 0,04% ) | 4 117 $ | 31.05.2024 |
Aktive Positionen von Carole Faig
Unternehmen | Position | Beginn |
---|---|---|
HENRY SCHEIN, INC. | Direktor/Vorstandsmitglied | 18.12.2023 |
Affinia Therapeutics, Inc.
![]() Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Direktor/Vorstandsmitglied | 01.09.2021 |
QuVa Pharma, Inc.
![]() QuVa Pharma, Inc. Pharmaceuticals: MajorHealth Technology QuVa Pharma, Inc. provides sterile compounding pharmacy services. It develops, manufactures and distributes compounded sterile preparations. The firm provides vital compounded medications for obstetrics, OR, anesthesia, general medicine, cardiovascular, ER, and pain management. The company was founded by Stuart Hinchen and Peter Linsay Jenkins in 2015 and is headquartered in Austin, TX. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Carole Faig
Unternehmen | Position | Ende |
---|---|---|
CUE HEALTH INC. | Direktor/Vorstandsmitglied | 24.05.2024 |
Ernst & Young LLP
![]() Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Ausbildung von Carole Faig
Sam Houston State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
CUE HEALTH INC. | Health Technology |
HENRY SCHEIN, INC. | Distribution Services |
Private Unternehmen | 3 |
---|---|
Affinia Therapeutics, Inc.
![]() Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Health Technology |
Ernst & Young LLP
![]() Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
QuVa Pharma, Inc.
![]() QuVa Pharma, Inc. Pharmaceuticals: MajorHealth Technology QuVa Pharma, Inc. provides sterile compounding pharmacy services. It develops, manufactures and distributes compounded sterile preparations. The firm provides vital compounded medications for obstetrics, OR, anesthesia, general medicine, cardiovascular, ER, and pain management. The company was founded by Stuart Hinchen and Peter Linsay Jenkins in 2015 and is headquartered in Austin, TX. | Health Technology |